News | January 24, 2007

New Stent Available for Carotid Interventions

Jan. 25, 2007 — ev3 Inc. has announced FDA approval of the PROTÉGÉ RX Carotid Stent, which, when used in conjunction with ev3’s SpideRX Embolic Protection Device, is indicated for the treatment of carotid artery disease in patients who are at high-risk for adverse events from carotid artery surgery.

The FDA approval was supported by the CREATE (Carotid Revascularization with ev3, Inc. Arterial Technology Evolution) Trial demonstrating the safety and effectiveness of the PROTÉGÉ stent in combination with the SPIDER Embolic Protection Device. Gary Ansel, M.D., Riverside Hospital, Columbus, Ohio, and Robert Safian, M.D., William Beaumont Hospital, Royal Oak, Mich.,
were the national co-principal investigators for the trial.

PROTÉGÉ RX is available in both straight and tapered stent configurations providing a variety of device options to address a broad range of patient anatomy present in carotid artery disease. The “rapid exchange” platform, the company says, allows for a single physician to operate the device as compared to “over the wire” designs that require multiple operators. The SpideRX Embolic Protection Device is the only available distal filter embolic protection device that permits physicians to use their guide wire of choice and is cleared by the FDA for use in both carotid arteries and saphenous vein grafts.

For further information, visit

Related Content

TCAR Achieves Favorable Outcomes Versus Carotid Endarterectomy in CAD Patients
News | Stents Carotid | June 13, 2019
Silk Road Medical Inc. announced the presentation of real-world data for the treatment of patients with carotid artery...
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid | November 18, 2016
November 18, 2016 — InspireMD Inc.
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid | October 13, 2016
A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in...
carotid artery stenting, outcomes, JACC, Beau Hawkins, Robert Yeh, CARE Registry
Feature | Stents Carotid | July 13, 2015
Hospitals performing carotid artery stenting vary considerably in rates of in-hospital stroke or death, according to a...
News | Stents Carotid | June 17, 2015
Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research,...
Overlay Init